Merck & Co. Inc. has dropped New Jersey’s Lowenstein Sandler from its appeal of a $13.5 million Vioxx case to prevent recusal of a potentially pro-company state Supreme Court justice who the firm represents in a private matter.

Lowenstein partner Douglas Eakeley, who won a split decision in the Appellate Division in May, won’t reprise his arguments in the state Supreme Court because since February he has been defending Justice Roberto Rivera-Soto against a complaint that the justice abused the power of his office to gain advantage in a private dispute.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]